ICRP Events


ICRP’s mission is to improve access to information about global cancer research funding, and enable cancer research funding organizations to work collaboratively to address common challenges. Our annual meetings are a great opportunity to connect with other cancer research funders, identify gaps in funding, explore options for collaborative funding and exchange innovative ideas. A summary of the 2019 Annual meeting can be found here  and please visit our library to view summaries of our previous meetings.

Due to the COVID-19 pandemic, our annual in-person meetings in 2020 and 2021 have been suspended.

Patient Engagement Virtual Workshop 2Patient engagement workshop

11 November, 2021 (09.00 CET, 19.00 AEDT)

Purpose of the session:

This introductory 1 hour session will explore what best practice looks like for patient/consumer engagement across the spectrum of cancer research, from basic to clinical research. During the session you will

  • Hear from a patient advocate and scientist involved in developing guidance for funders
  • Explore how funders can promote best practice in patient engagement in an interactive forum
  • Have the opportunity to join a working group to effect cultural change in the involvement of patients in funding decisions and in evaluating the impact of cancer research


  • Jan Geissler - patient advocate and social entrepreneur, founder of Patvocates
  • Cordula Landgraf - head of communications and stakeholder engagement at the Swiss Clinical Trial Organization

Who should attend:

Representatives of cancer research funding organizations across the world are invited to attend. Two sessions are scheduled to enable participation in different time zones. This advertisement relates to the second meeting planned for 11 November 2021 at 09.00 CET, enabling participation in time zones in Europe/Asia/Australia (equates to 19.00 Australian Eastern Daylight Time).

How to register:

Co-hosted by the Rising Tide Foundation for Clinical Cancer Research and ICRP. f you have any questions, or want to be included on the mailing list, please contact us.

Please note: this is a second introductory session, covering the same content as the initial workshop on 10 September for US/UK/EU time zones. 


How collaboration is advancing research and clinical care in paediatric cancer (19 April 2021)

  • Co-Chairs: Ms Amy Weinstein (Director of Research, Pediatric Brain Tumor Foundation, US); Dr. Julia Chisholm (Chair, National Cancer Research Institute Children's Group, UK)
  • Speakers: Professor Vickie Buenger (President, Coalition Against Childhood Cancer, US); Professor Gilles Vassal (Professor of Oncology, Universite de Paris-Sud, ITCC President, Chair - ACCELERATE network)
  • About the session: This session, jointly organised by the International Cancer Research Partnership (ICRP) and the UK’s National Cancer Research Institute (NCRI), highlighted how cancer research funders are currently collaborating to advance paediatric cancer research and clinical care; and galvanised support for more international collaboration to maximise investments in funding.

Addressing disparities in international cancer research (22 March 2021)

  • Chair: Professor Richard Sullivan, King's College London, UK
  • Speakers: Sigourney Bell, BSc (Co-founder, Blackincancer), Aisha Lofters MD, PhD CCFP (Peter Gilgan Centre for Women’s Cancers, Women’s College Hospital, Toronto, Canada), Geetanjali Datta ScD, MPH (Cedars-Sinai Cancer Research Center for Health Equity, USA)
  • About the session: this session focused on highlighting disparities in cancer research funding and identifying best practice for international funders in addressing disparities. The panel discussed global cancer inequalities, mentoring black cancer researchers and promoting community cancer awareness, patient-centred approaches to removing barriers to participation in cancer screening and prevention, and transforming race-based cancer research.

Exploring Global Partnerships in Cancer Research Funding (18 February 2021)

  • Chair: Dr Ian Lewis, NCRI, UK
  • Speakers: Cancer Australia, Cancer Research UK, Melanoma Research Alliance, US National Cancer Institute Center for Global Health, World Cancer Research Fund International, Worldwide Cancer Research.
  • About the session: this session, jointly organized with the UK’s National Cancer Research Institute, focused on the benefits of collaboration between international cancer research funders, the impact that COVID-19 has had on funding, and opportunities for future collaborations. Delegates heard from a selection of organisations who have set up successful international collaborative funding opportunities to address gaps in cancer research, and also learn about best practice in establishing international collaborative funding streams. 
Meeting Report Title

Newsletter Summary of annual meeting"
Download PDF